First-trimester combined screening: experience with an instant results approach
- PMID: 17547916
- PMCID: PMC2099455
- DOI: 10.1016/j.ajog.2007.03.019
First-trimester combined screening: experience with an instant results approach
Abstract
Objective: This study was undertaken to assess an instant results protocol for first-trimester combined screening.
Study design: Retrospective analysis of patients having first-trimester combined screening between Nov. 1, 2003 and Oct. 31, 2005. We evaluated the feasibility of patient self-collection and mail-in of blood samples before nuchal translucency ultrasound. Primary outcome was success with providing in-office, immediate screening results after the ultrasound. Predictor variables included age, ethnicity, insurance, and provider. The chi2 analysis was performed.
Results: Two thousand three hundred ten women completed first-trimester combined screening, and 60.6% received instant results. When the biochemistry sample was collected at home, 80% received instant results. Age 35 years or older predicted instant results (P = .001), whereas ethnicity, insurance, and referring provider did not. Comparing the prior 24 months, clinic volume increased by 18%. Diagnostic procedure volume was unchanged, although chorionic villus sampling increased by 12% (P = .02) and amniocentesis decreased by 6% (P = .049).
Conclusion: Patients were able to obtain instant results in 60.6% of cases, which appeared to increase the use of chorionic villus sampling.
Figures
Similar articles
-
Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.BJOG. 2003 Mar;110(3):276-80. BJOG. 2003. PMID: 12628267
-
If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.Acta Obstet Gynecol Scand. 2006;85(5):534-8. doi: 10.1080/00016340500523701. Acta Obstet Gynecol Scand. 2006. PMID: 16752230
-
Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?Am J Obstet Gynecol. 2004 Mar;190(3):769-74. doi: 10.1016/j.ajog.2003.09.067. Am J Obstet Gynecol. 2004. PMID: 15042012
-
First-trimester screening: an overview.J Histochem Cytochem. 2005 Mar;53(3):281-3. doi: 10.1369/jhc.4B6420.2005. J Histochem Cytochem. 2005. PMID: 15750002 Review.
-
Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities.Arch Gynecol Obstet. 2017 Oct;296(4):645-651. doi: 10.1007/s00404-017-4459-9. Epub 2017 Jul 12. Arch Gynecol Obstet. 2017. PMID: 28702698 Review.
Cited by
-
Early pregnancy prediction of gestational diabetes mellitus risk using prenatal screening biomarkers in nulliparous women.Diabetes Res Clin Pract. 2020 May;163:108139. doi: 10.1016/j.diabres.2020.108139. Epub 2020 Apr 6. Diabetes Res Clin Pract. 2020. PMID: 32272192 Free PMC article.
References
-
- Malone FD, et al. First or second trimester screening for Down syndrome or both. N Engl J Med. 2005 Nov 10;353(19):2001–11. - PubMed
-
- Wapner R, Thom E, Simpson JL, et al. First trimester screening for trisomies 21 and 18. New Engl J Med. 2003;349:1405–13. - PubMed
-
- Learman LA, Drey EA, Gates EA, Kang MS, Washington AE, Kuppermann M. Abortion attitudes of pregnant women in prenatal care. Am J Obstet Gynecol. 2005;192:1939–45. - PubMed
-
- Wald NJ, Rodeck C, Hackshaw AJ, et al. First and second trimester antenatal screening for Down syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) J Med Screen. 2003;10(2):56–104. - PubMed
-
- Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet. 1998;352:343–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources